USD 3.79
(-2.07%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 76.15 Million USD | 580.64% |
2022 | 10.29 Million USD | 182.75% |
2021 | 9000.00 USD | -78.09% |
2020 | 3.43 Million USD | -256.42% |
2019 | 15.52 Million USD | -86.77% |
2018 | 34.88 Million USD | 64.75% |
2017 | 34.14 Million USD | 6.79% |
2016 | 26.01 Million USD | 47.34% |
2015 | 8.05 Million USD | 244.86% |
2014 | -3.99 Million USD | 57.36% |
2013 | -13.91 Million USD | -146.9% |
2012 | -9.09 Million USD | 0.73% |
2011 | -4.5 Million USD | -182.96% |
2010 | -168.49 Thousand USD | -62.47% |
2009 | -5.02 Million USD | 88.89% |
2008 | -5.01 Million USD | -9293.74% |
2007 | 1.51 Million USD | -97.41% |
2006 | 7.38 Million USD | -24.15% |
2005 | 9.91 Million USD | 733.25% |
2004 | 1.13 Million USD | -12.33% |
2003 | 1.29 Million USD | 199.22% |
2002 | -1.36 Million USD | 11.63% |
2001 | -1.88 Million USD | -139.28% |
2000 | -4.42 Million USD | 245.17% |
1999 | -2.7 Million USD | -42.11% |
1998 | -1.5 Million USD | 62.75% |
1997 | -4.3 Million USD | 46.88% |
1996 | -4.2 Million USD | 48.94% |
1995 | -10.1 Million USD | -27.03% |
1994 | -14.7 Million USD | -34.55% |
1993 | -12.3 Million USD | -64.18% |
1992 | -6.4 Million USD | -52.27% |
1991 | -4.2 Million USD | -50.0% |
1990 | -2.8 Million USD | -16.67% |
1989 | -2.4 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -626 Thousand USD | -104.77% |
2024 Q2 | 2.57 Million USD | 180.66% |
2023 FY | - USD | 580.64% |
2023 Q4 | 11.3 Million USD | 3.76% |
2023 Q2 | -6.06 Million USD | -120.11% |
2023 Q1 | 30.17 Million USD | 129.83% |
2023 Q3 | 10.89 Million USD | 279.5% |
2022 Q4 | 13.13 Million USD | -27.12% |
2022 Q1 | -12.28 Million USD | -32.29% |
2022 Q2 | 3.81 Million USD | 131.01% |
2022 FY | - USD | 182.75% |
2022 Q3 | 18.01 Million USD | 372.91% |
2021 Q2 | 1.35 Million USD | -88.13% |
2021 Q3 | -14.01 Million USD | -1131.89% |
2021 Q1 | 11.43 Million USD | 133.08% |
2021 Q4 | -9.28 Million USD | 33.71% |
2021 FY | - USD | -78.09% |
2020 Q1 | -5.82 Million USD | -187.73% |
2020 FY | - USD | -256.42% |
2020 Q2 | -8.31 Million USD | -42.77% |
2020 Q3 | 4.26 Million USD | 151.27% |
2020 Q4 | 4.9 Million USD | 15.05% |
2019 FY | - USD | -86.77% |
2019 Q4 | 6.64 Million USD | 155.25% |
2019 Q1 | 505 Thousand USD | -95.96% |
2019 Q3 | -12.02 Million USD | -307.85% |
2019 Q2 | 5.78 Million USD | 1045.15% |
2018 Q2 | 7.43 Million USD | 442.77% |
2018 FY | - USD | 64.75% |
2018 Q3 | 12.69 Million USD | 70.78% |
2018 Q4 | 12.51 Million USD | -1.47% |
2018 Q1 | 1.37 Million USD | -88.56% |
2017 Q2 | 8.37 Million USD | 208.41% |
2017 FY | - USD | 6.79% |
2017 Q4 | 11.97 Million USD | 32.79% |
2017 Q3 | 9.01 Million USD | 7.73% |
2017 Q1 | -7.72 Million USD | -209.16% |
2016 Q1 | 4.05 Million USD | -26.7% |
2016 Q2 | 5.77 Million USD | 42.44% |
2016 FY | - USD | 47.34% |
2016 Q3 | 7.57 Million USD | 31.27% |
2016 Q4 | 7.07 Million USD | -6.66% |
2015 FY | - USD | 244.86% |
2015 Q4 | 5.52 Million USD | 259.96% |
2015 Q3 | 1.53 Million USD | -63.09% |
2015 Q1 | 1.11 Million USD | 213.16% |
2015 Q2 | 4.16 Million USD | 272.18% |
2014 FY | - USD | 57.36% |
2014 Q1 | -4.07 Million USD | 54.12% |
2014 Q4 | -988 Thousand USD | -212.02% |
2014 Q3 | 882 Thousand USD | 112.72% |
2014 Q2 | -6.93 Million USD | -69.99% |
2013 Q4 | -8.89 Million USD | -331.6% |
2013 Q3 | -2.06 Million USD | 47.38% |
2013 Q2 | -3.91 Million USD | 56.66% |
2013 FY | - USD | -146.9% |
2013 Q1 | -9.03 Million USD | -46.89% |
2012 Q4 | -6.15 Million USD | -112.51% |
2012 Q3 | -2.89 Million USD | 15.55% |
2012 Q2 | -3.42 Million USD | 2.95% |
2012 Q1 | -3.53 Million USD | -320.2% |
2012 FY | - USD | 0.73% |
2011 Q3 | -4.17 Million USD | -83.07% |
2011 FY | - USD | -182.96% |
2011 Q4 | 1.6 Million USD | 138.42% |
2011 Q2 | -2.28 Million USD | -35.32% |
2011 Q1 | -1.68 Million USD | -21268.07% |
2010 Q4 | -7885.00 USD | -100.71% |
2010 FY | - USD | -62.47% |
2010 Q1 | -2.15 Million USD | 19.14% |
2010 Q2 | -517 Thousand USD | 76.03% |
2010 Q3 | 1.1 Million USD | 314.18% |
2009 Q1 | -676.88 Thousand USD | 86.28% |
2009 FY | - USD | 88.89% |
2009 Q2 | -1.21 Million USD | -79.5% |
2009 Q4 | -2.66 Million USD | -203.37% |
2009 Q3 | 2.58 Million USD | 312.39% |
2008 Q3 | -2.62 Million USD | 15.6% |
2008 FY | - USD | -9293.74% |
2008 Q1 | -7.13 Million USD | -1078.09% |
2008 Q2 | -3.1 Million USD | 56.45% |
2008 Q4 | -4.93 Million USD | -88.23% |
2007 Q1 | -166.96 Thousand USD | -257.71% |
2007 FY | - USD | -97.41% |
2007 Q2 | 1.25 Million USD | 853.43% |
2007 Q4 | -605.34 Thousand USD | -107.21% |
2007 Q3 | -292.13 Thousand USD | -123.22% |
2006 Q4 | 105.87 Thousand USD | -96.51% |
2006 FY | - USD | -24.15% |
2006 Q2 | 2.98 Million USD | 121.2% |
2006 Q3 | 3.03 Million USD | 1.48% |
2006 Q1 | 1.35 Million USD | -49.98% |
2005 Q2 | 1.52 Million USD | -17.52% |
2005 FY | - USD | 733.25% |
2005 Q4 | 2.7 Million USD | -28.81% |
2005 Q3 | 3.79 Million USD | 149.51% |
2005 Q1 | 1.84 Million USD | 769.13% |
2004 FY | - USD | -12.33% |
2004 Q4 | 212.17 Thousand USD | 46.53% |
2004 Q3 | 144.79 Thousand USD | -73.61% |
2004 Q2 | 548.59 Thousand USD | 97.33% |
2004 Q1 | 278.01 Thousand USD | -74.86% |
2003 Q2 | 90.6 Thousand USD | 118.95% |
2003 Q1 | -498.1 Thousand USD | -195.12% |
2003 Q3 | 656.99 Thousand USD | 586.49% |
2003 Q4 | 1.04 Million USD | 70.64% |
2003 FY | - USD | 199.22% |
2002 FY | - USD | 11.63% |
2002 Q4 | 523.63 Thousand USD | 234.84% |
2002 Q2 | -866.47 Thousand USD | 25.95% |
2002 Q1 | -1.17 Million USD | 25.66% |
2002 Q3 | 154.11 Thousand USD | 118.01% |
2001 Q4 | -1.47 Million USD | -360.76% |
2001 Q1 | -315.38 Thousand USD | -96.0% |
2001 Q3 | 490.02 Thousand USD | 420.56% |
2001 Q2 | -134.24 Thousand USD | -364.56% |
2001 FY | - USD | -139.28% |
2000 FY | - USD | 245.17% |
2000 Q4 | 31.71 Thousand USD | -58.94% |
2000 Q3 | -1.53 Million USD | 390.39% |
2000 Q2 | -894.75 Thousand USD | -72.16% |
2000 Q1 | -869.14 Thousand USD | -110.73% |
1999 FY | - USD | -42.11% |
1999 Q4 | -415.22 Thousand USD | 41.14% |
1999 Q3 | -700 Thousand USD | -75.0% |
1999 Q2 | -400 Thousand USD | 50.0% |
1999 Q1 | -700 Thousand USD | 11.11% |
1998 Q3 | 100 Thousand USD | 150.0% |
1998 FY | - USD | 62.75% |
1998 Q1 | -700 Thousand USD | 20.0% |
1998 Q2 | -100 Thousand USD | 75.0% |
1998 Q4 | -800 Thousand USD | -1000.0% |
1997 FY | - USD | 46.88% |
1997 Q4 | -900 Thousand USD | 44.44% |
1997 Q3 | 1.2 Million USD | 21.74% |
1997 Q2 | -1.9 Million USD | -15.0% |
1997 Q1 | -900 Thousand USD | -154.05% |
1996 FY | - USD | 48.94% |
1996 Q4 | -500 Thousand USD | 428.57% |
1996 Q3 | 700 Thousand USD | 109.86% |
1996 Q2 | -1.7 Million USD | -255.0% |
1996 Q1 | -1.8 Million USD | -11.11% |
1995 Q3 | -5.3 Million USD | -27.91% |
1995 Q2 | -4 Million USD | 10.42% |
1995 Q1 | -4.6 Million USD | -14.29% |
1995 FY | - USD | -27.03% |
1995 Q4 | -1.6 Million USD | 67.27% |
1994 FY | - USD | -34.55% |
1994 Q4 | -4.1 Million USD | 2.33% |
1994 Q3 | -4.3 Million USD | -16.22% |
1994 Q2 | -3.6 Million USD | 9.76% |
1994 Q1 | -4.1 Million USD | -57.69% |
1993 Q1 | -3 Million USD | 42.86% |
1993 FY | - USD | -64.18% |
1993 Q2 | -3 Million USD | -87.5% |
1993 Q3 | -3.5 Million USD | -16.67% |
1993 Q4 | -2.6 Million USD | 25.71% |
1992 Q4 | -2.8 Million USD | -33.33% |
1992 Q2 | -1.4 Million USD | 0.0% |
1992 Q3 | -2.1 Million USD | -40.0% |
1992 FY | - USD | -52.27% |
1992 Q1 | -1.5 Million USD | 6.25% |
1991 FY | - USD | -37.5% |
1991 Q1 | -1.2 Million USD | -62.5% |
1991 Q2 | -900 Thousand USD | 23.08% |
1991 Q3 | -1.5 Million USD | -50.0% |
1991 Q4 | -1.5 Million USD | -6.67% |
1990 Q3 | -300 Thousand USD | 66.67% |
1990 FY | - USD | -23.08% |
1990 Q1 | -800 Thousand USD | -28.57% |
1990 Q2 | -1.1 Million USD | -33.33% |
1990 Q4 | -700 Thousand USD | -100.0% |
1989 Q2 | -500 Thousand USD | -175.0% |
1989 FY | - USD | 0.0% |
1989 Q1 | 800 Thousand USD | 200.0% |
1989 Q4 | -600 Thousand USD | -16.67% |
1989 Q3 | -500 Thousand USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Akoya Biosciences, Inc. | -45.63 Million USD | 266.896% |
AngioDynamics, Inc. | -14.29 Million USD | 632.872% |
AtriCure, Inc. | -8.1 Million USD | 1039.179% |
Avinger, Inc. | -16.34 Million USD | 565.912% |
Azenta, Inc. | 55.15 Million USD | -38.09% |
BioLife Solutions, Inc. | -45.23 Million USD | 268.35% |
The Cooper Companies, Inc. | 882.8 Million USD | 91.373% |
Daxor Corporation | 329.74 Thousand USD | -22996.379% |
Ekso Bionics Holdings, Inc. | -13.19 Million USD | 677.042% |
Femasys Inc. | -13.16 Million USD | 678.295% |
GlucoTrack, Inc. | -7.09 Million USD | 1174.009% |
Harvard Bioscience, Inc. | 9.49 Million USD | -702.254% |
Hologic, Inc. | 1.29 Billion USD | 94.125% |
ICU Medical, Inc. | 307.69 Million USD | 75.249% |
Intuitive Surgical, Inc. | 2.39 Billion USD | 96.819% |
KORU Medical Systems, Inc. | -9.39 Million USD | 910.227% |
LeMaitre Vascular, Inc. | 48.99 Million USD | -55.456% |
Innovative Eyewear, Inc. | -6.57 Million USD | 1258.273% |
Innovative Eyewear, Inc. | -6.57 Million USD | 1258.273% |
Masimo Corporation | 236.7 Million USD | 67.825% |
Microbot Medical Inc. | -10.63 Million USD | 816.175% |
Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -382.913% |
Merit Medical Systems, Inc. | 231.44 Million USD | 67.094% |
Nephros, Inc. | -1.37 Million USD | 5622.698% |
NovoCure Limited | -175.86 Million USD | 143.305% |
NEXGEL, Inc. | -2.73 Million USD | 2889.67% |
NEXGEL, Inc. | -2.73 Million USD | 2889.67% |
Singular Genomics Systems, Inc. | -86.49 Million USD | 188.048% |
Pro-Dex, Inc. | 8.33 Million USD | -813.933% |
Pulse Biosciences, Inc. | -42.36 Million USD | 279.758% |
Predictive Oncology Inc. | -13.18 Million USD | 677.742% |
Precision Optics Corporation, Inc. | -2.51 Million USD | 3131.827% |
QuidelOrtho Corporation | 545.6 Million USD | 86.041% |
Repligen Corporation | 124.29 Million USD | 38.727% |
Sanara MedTech Inc. | -289.09 Thousand USD | 26443.407% |
STAAR Surgical Company | 33.22 Million USD | -129.247% |
Sharps Technology, Inc. | -8.98 Million USD | 948.048% |
Utah Medical Products, Inc. | 24.8 Million USD | -207.027% |
DENTSPLY SIRONA Inc. | 232 Million USD | 67.173% |
Jin Medical International Ltd. | 3.44 Million USD | -2112.04% |